DOCSLIB.ORG

Dichloroxylenol (BAN, Rinn) C18h40cln = 306.0

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dichloroxylenol (BAN, Rinn) C18h40cln = 306.0 1642 Disinfectants and Preservatives Preparations Profile Almyrol; Baccalin†; Bacillocid rasant†; Desoform†; Freka-Nol; Fugisept†; Gercid forte†; Gigasept Med†; Hexaquart L†; Hexaquart plus; Hexaquart Proprietary Preparations (details are given in Part 3) Dichlorobenzyl alcohol is an antiseptic used chiefly as an ingre- dient of lozenges in the treatment of minor infections of the S; Inova†; Kohrsolin FF; Korsolex Extra; Korsolex FF; Korsolex Plus; Lysofor- Multi-ingredient: Austria: Dermowund. min 3000; Lysoformin spezial; Meliseptol Rapid; Melsept SF; Melsitt; Quato- mouth and throat. hex; Teta Extra; Ital.: Melsept SF; Switz.: Desamon; Thai.: Deconex Preparations 53IN†; USA: Vi Rid-Ready. Dibrompropamidine Isetionate (BANM, rINNM) Proprietary Preparations (details are given in Part 3) Ital.: Neo Borocillina Collutorio; Neo Borocillina Spray. Dibromipropamidiinidi-isetionaatti; Dibromopropamidine Ise- Multi-ingredient: Austral.: Ayrton’s Antiseptic; Logicin Rapid Relief; 1,6-Dihydroxy-2,5-dioxahexane thionate; Dibromopropamidyny diizetionian; Dibrompropa- Sore Throat Chewing Gum†; Strepsils; Strepsils Plus; Austria: Coldangin; midindiisetionat; Dibrompropamidin-diisetionát; Dibrompropa- Neo-Angin; Sulgan 99; Belg.: Neofenox; Strepsils; Strepsils + Lidocaine; Ethylene Glycol Bis(semiformal); (Ethylenedioxy)dimethanol. midine Diisetionate; Dibrompropamidine, diisétionate de; Di- Strepsils Menthol; Strepsils Vit C; Canad.: Strepsils; Strepsils Cherry†; [1,2-Ethanediylbis(oxy)]bismethanol. Chile: Cornina†; Hansaplast Antimicotico; Cz.: Neo-Angin; Strepsils; brompropamidine, Isétionate de; Dibrompropamidini diisetio- Strepsils Menthol a Eucalyptus; Strepsils Plus; Strepsils Vitamin C; Denm.: C4H10O4 = 122.1. nas; Dibrompropamidini Isetionas; Isetionato de dibrompropa- Strepsils; Fin.: Bafucin; Strepsils; Strepsils Menthol; Fr.: Strepsils; Strepsils CAS — 3586-55-8. midina. 3,3′-Dibromo-4,4′-trimethylenedioxydibenzamidine bis(2- Lidocaine; Strepsils Miel-Citron; Strepsils Vitamine C; Strepsilspray Lido- caine; Ger.: Dobendan Synergie; Neo-Angin; Gr.: Strepsils; Hong Kong: hydroxyethanesulphonate). Logicin Rapid Relief; Strepsils; Strepsils Dual Action; Hung.: Neo-Angin; Дибромпропамидина Изетионат Strepsils; Strepsils Menthol and Eucalyptus; Strepsils Plus; Strepsils Vitamin C; India: Cofsils†; Irl.: Strepsils; Strepsils +Plus Anaesthetic; Strepsils Dual O OH C17H18Br2N4O2,2C2H6O4S = 722.4. Action; Strepsils Vitamin C; Israel: Strepsils; Strepsils Plus; Strepsils with HO O CAS — 496-00-4 (dibrompropamidine); 614-87-9 (di- Menthol and Eucalyptus; Strepsils with Vitamin C; Ital.: Arscolloid; Benagol; brompropamidine isetionate). Benagol Mentolo-Eucaliptolo; Benagol Vitamina C; Bio-Arscolloid; Corti- ATC — D08AC01; S01AX14. Arscolloid; Farmagola†; Neo Borocillina; Neo Borocillina Balsamica; Neo Profile 1,6-Dihydroxy-2,5,-dioxahexane is an aldehyde that slowly re- ATC Vet — QD08AC01; QS01AX14. Borocillina C; Neo Borocillina Tosse Compresse; Malaysia: Chericof; Strepsils; Strepsils Dual Action; Neth.: Strepsils; Strepsils Menthol en Euca- leases formaldehyde. It is used for the disinfection of surfaces lyptus; Strepsils Sinaasappel en Vitamine C; NZ: Strepsils; Strepsils Plus An- and of medical and surgical instruments. aesthetic; Strepsils with Vitamin C; Philipp.: Strepsils; Pol.: Neo-Angin; O O Strepsils; Port.: Benoral; Dropcina; Rus.: Astrasept (Астрасепт); Coldact Preparations Lorpils (Колдакт Лорпилс)†; Rinza Lorsept (Ринза Лорсепт); Strepsils (Стрепсилс); Strepsils Plus (Стрепсилс Плюс); Suprima-Lor (Суприма- Proprietary Preparations (details are given in Part 3) H2N NH2 Лор); S.Afr.: Strepsils; Strepsils Eucalyptus Menthol; Strepsils Orange-C; Br Br Strepsils Plus; Strepsils Soothing Honey & Lemon; Singapore: Strepsils; Multi-ingredient: Ger.: Bacillol; Kohrsolin; Korsolex basic; Korsolex Ex- Strepsils Dual Action; Spain: Strepsils; Strepsils con Vitamina C; Strepsils tra. NH NH Lidocaina; Swed.: Bafucin; Strepsils; Switz.: Anginazol; Hextriletten; Lida- zon; Neo-Angin au miel et citron; Neo-Angin avec vitamin C sans sucre; (dibrompropamidine) Neo-Angin sans sucre; Sulgan N; Thai.: Strepsils Butter Menthol Capsicum; Strepsils Plus Anaesthetic; Strepsils Plus Vit C; Strepsils Sugar Free; Throatsil; Turk.: Strepsils; Strepsils C; Strepsils Mentollu; UK: Strepsils; Strepsils with Dioctyldimethylammonium Chloride Pharmacopoeias. In Eur. (see p.vii). Vitamin C. Ph. Eur. 6.2 (Dibrompropamidine Diisetionate). A white or al- Dimethyldioctylammonium Chloride; Dioctyl Dimethyl Ammo- most white, crystalline powder. Freely soluble or soluble in wa- nium Chloride. N,N-Dimethyl-N-octyl-1-octanaminium chloride. ter; slightly soluble in alcohol; practically insoluble in dichlo- Диоктилдиметиламмония Хлорид romethane. A 5% solution in water has a pH of 5.0 to 6.0. Dichloroxylenol (BAN, rINN) C18H40ClN = 306.0. Profile DCMX; Dichlorometaxylenol; Dichloroxylénol; Dichloroxyleno- CAS — 5538-94-3. Dibrompropamidine isetionate is an aromatic diamidine antisep- lum; Dicloroxilenol. 2,4-Dichloro-3,5-xylenol; 2,4-Dichloro-3,5- tic similar to propamidine (p.1660). It is bactericidal against dimethylphenol. Gram-positive bacteria but is less active against Gram-negative Дихлороксиленол H C bacteria and spore-forming organisms. It also has antifungal 3 C8H8Cl2O = 191.1. properties. It is available as topical preparations for the local CAS — 133-53-9. treatment of minor eye and skin infections. Cl Preparations Proprietary Preparations (details are given in Part 3) H3C OH Austral.: Brolene; Brulidine; Irl.: Brolene; Norw.: Brulidine; NZ: Brolene; CH3 UK: Brolene; Brulidine; Golden Eye Ointment; Pickles Antiseptic Cream. N Multi-ingredient: UK: Healthy Feet; No-Sor Nose Balm; RBC; Swarm. Cl Cl CH3 CH3 Dichlordimethylhydantoin Profile Diclorodimetilhidantoína. 1,3-Dichloro-5,5-dimethylhydantoin; CH3 1,3-Dichloro-5,5-dimethylimidazolidine-2,4-dione. Dichloroxylenol is a chlorinated phenolic antiseptic. C5H6Cl2N2O2 = 197.0. Preparations CAS — 118-52-5. Profile Proprietary Preparations (details are given in Part 3) Dioctyldimethylammonium chloride is a quaternary ammonium Multi-ingredient: India: Fairgenol†; UAE: Radol. disinfectant used in preparations for disinfection of surfaces. Cl Preparations N Proprietary Preparations (details are given in Part 3) O O Didecyldimethylammonium Chloride Didecildimetilamonio, cloruro de; Didecyldimonium Chloride. Multi-ingredient: USA: Vi Rid-Ready. N N-Decyl-N,N-demethyl-l-decanaminium chloride. H3C Cl C22H48ClN = 362.1. H3C CAS — 7173-51-5. Dodeclonium Bromide (rINN) ATC — D08AJ06. Profile ATC Vet — QD08AJ06. Bromuro de dodeclonio; Dodeclonii Bromidum; Dodéclonium, Dichlordimethylhydantoin is a disinfectant used as a source of Bromure de; GR-412. [2-(p-Chlorophenoxy)ethyl]dodecyld- chlorine, for sterilising food and dairy equipment and as a bleach. imethylammonium bromide. It contains about 72% w/w of ‘available chlorine’ (see p.1638). HC Додеклония Бромид Bromochlorodimethylhydantoin (C5H6N2O2BrCl = 241.5) is a closely related bromine-releasing compound used for the disin- Cl C22H39BrClNO = 448.9. fection of swimming-pool water. CAS — 15687-13-5. CH N Cl Dichlorobenzyl Alcohol CH - Alcohol diclorobencílico; 2,4-Dichlorbenzyl-alcoholum; Dichlo- Br CH3 rophenylcarbinol; 2,4-Diklooribentsyyli-alkoholi; 2,4-Diklorben- + H3C N sylalkohol; Diklorobenzil Alkol. 2,4-Dichlorobenzyl alcohol. CH O C7H6Cl2O = 177.0. H3C CAS — 1777-82-8. ATC — R02AA03. Profile ATC Vet — QR02AA03. Didecyldimethylammonium chloride is a quaternary ammonium Profile disinfectant used in preparations for disinfection of the skin and Dodeclonium bromide is an antiseptic that has been included in mucous membranes. It is also used to disinfect instruments and multi-ingredient preparations intended for the treatment of skin Cl surfaces. and anorectal disorders. Preparations Preparations Cl Proprietary Preparations (details are given in Part 3) Proprietary Preparations (details are given in Part 3) Ger.: Amosept; Fungisept; Ital.: Alfa; Farmasept; Thai.: Deconex 50FF†. Multi-ingredient: Belg.: Biogaze; Fr.: Sedorrhoide. HO Multi-ingredient: Fr.: Aniospray 29; Aniospray 41; Aniosyme; Bacterian- os D†; Chlorispray†; Hexanios G+R; Oxitou; Sanytol†; Surfanios; Ger.:.
Load more

Recommended publications
  • Classification of Medicinal Drugs and Driving: Co-Ordination and Synthesis Report
    Project No. TREN-05-FP6TR-S07.61320-518404-DRUID DRUID Driving under the Influence of Drugs, Alcohol and Medicines Integrated Project 1.6. Sustainable Development, Global Change and Ecosystem 1.6.2: Sustainable Surface Transport 6th Framework Programme Deliverable 4.4.1 Classification of medicinal drugs and driving: Co-ordination and synthesis report. Due date of deliverable: 21.07.2011 Actual submission date: 21.07.2011 Revision date: 21.07.2011 Start date of project: 15.10.2006 Duration: 48 months Organisation name of lead contractor for this deliverable: UVA Revision 0.0 Project co-funded by the European Commission within the Sixth Framework Programme (2002-2006) Dissemination Level PU Public PP Restricted to other programme participants (including the Commission x Services) RE Restricted to a group specified by the consortium (including the Commission Services) CO Confidential, only for members of the consortium (including the Commission Services) DRUID 6th Framework Programme Deliverable D.4.4.1 Classification of medicinal drugs and driving: Co-ordination and synthesis report. Page 1 of 243 Classification of medicinal drugs and driving: Co-ordination and synthesis report. Authors Trinidad Gómez-Talegón, Inmaculada Fierro, M. Carmen Del Río, F. Javier Álvarez (UVa, University of Valladolid, Spain) Partners - Silvia Ravera, Susana Monteiro, Han de Gier (RUGPha, University of Groningen, the Netherlands) - Gertrude Van der Linden, Sara-Ann Legrand, Kristof Pil, Alain Verstraete (UGent, Ghent University, Belgium) - Michel Mallaret, Charles Mercier-Guyon, Isabelle Mercier-Guyon (UGren, University of Grenoble, Centre Regional de Pharmacovigilance, France) - Katerina Touliou (CERT-HIT, Centre for Research and Technology Hellas, Greece) - Michael Hei βing (BASt, Bundesanstalt für Straßenwesen, Germany).
    [Show full text]
  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
    MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01
    [Show full text]
  • Drug Tariff Part VIIIA December 2019
    12/2019 Part VIIIA BASIC PRICES OF DRUGS Drug Quantity Basic Price Category Part VIIIA - Basic Prices of Drugs Product List Part VIIIA products A Abacavir 600mg / Lamivudine 30 19000 C Lupin Healthcare 300mg tablets (UK) Ltd Abatacept 125mg/1ml solution for 4 120960 C Orencia ClickJect injection pre-filled disposable devices Abatacept 125mg/1ml solution for 4 120960 C Orencia injection pre-filled syringes Acacia spray dried powder 250 g 1632 C J M Loveridge Ltd Acamprosate 333mg gastro- 168 3770 K A resistant tablets Acarbose 100mg tablets 90 2529 A Acarbose 50mg tablets 90 1458 A Acebutolol 100mg capsules 84 1497 C Sectral Acebutolol 200mg capsules 56 1918 C Sectral Acebutolol 400mg tablets 28 1862 C Sectral Aceclofenac 100mg tablets 60 962 A Acenocoumarol 1mg tablets 100 462 C Sinthrome Acetazolamide 250mg modified- 30 1666 C Diamox SR release capsules Acetazolamide 250mg tablets 112 1029 M Acetic acid 2% ear spray S 5ml 410 C EarCalm Acetone liquid 50 ml 112 A Acetylcysteine 200mg oral powder 30 11250 A sachets sugar free Acetylcysteine 2g/10ml solution for 10 2126 C Martindale infusion ampoules Pharmaceuticals Ltd Acetylcysteine 5% eye drops S 10 ml 3346 C Ilube Acetylcysteine 600mg capsules 30 3998 A Acetylcysteine 600mg effervescent 30 550 C tablets sugar free Aciclovir 200mg dispersible tablets 25 147 A Aciclovir 200mg tablets 25 133 M Aciclovir 200mg/5ml oral 125 ml 3578 A suspension sugar free Aciclovir 3% eye ointment S 4.5 g 934 C Zovirax Aciclovir 400mg dispersible tablets 56 1199 A Aciclovir 400mg tablets 56 310 M Aciclovir
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM LIDADRONICUM 63132-38-7 ABAFUNGIN 129639-79-8 ACIDUM SALCAPROZICUM 183990-46-7 ABAMECTIN 65195-55-3 ACIDUM SALCLOBUZICUM 387825-03-8 ABANOQUIL 90402-40-7 ACIFRAN 72420-38-3 ABAPERIDONUM 183849-43-6 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABATACEPTUM 332348-12-6 ACITEMATE 101197-99-3 ABCIXIMAB 143653-53-6 ACITRETIN 55079-83-9 ABECARNIL 111841-85-1 ACIVICIN 42228-92-2 ABETIMUSUM 167362-48-3 ACLANTATE 39633-62-0 ABIRATERONE 154229-19-3 ACLARUBICIN 57576-44-0 ABITESARTAN 137882-98-5 ACLATONIUM NAPADISILATE 55077-30-0 ABLUKAST 96566-25-5 ACODAZOLE 79152-85-5 ABRINEURINUM 178535-93-8 ACOLBIFENUM 182167-02-8 ABUNIDAZOLE 91017-58-2 ACONIAZIDE 13410-86-1 ACADESINE 2627-69-2 ACOTIAMIDUM 185106-16-5 ACAMPROSATE 77337-76-9
    [Show full text]
  • L:\0901 with Peru\0901PHARMAPPX.Wpd
    Harmonized Tariff Schedule of the United States (2009) (Rev. 1) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2009) (Rev. 1) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACEXAMIC ACID 57-08-9 ABAFUNGIN 129639-79-8 ACICLOVIR 59277-89-3 ABAMECTIN 65195-55-3 ACIFRAN 72420-38-3 ABANOQUIL 90402-40-7 ACIPIMOX 51037-30-0 ABAPERIDONE 183849-43-6 ACITAZANOLAST 114607-46-4 ABARELIX 183552-38-7 ACITEMATE 101197-99-3 ABATACEPT 332348-12-6 ACITRETIN 55079-83-9 ABCIXIMAB 143653-53-6 ACIVICIN 42228-92-2 ABECARNIL 111841-85-1 ACLANTATE 39633-62-0 ABETIMUS 167362-48-3 ACLARUBICIN 57576-44-0 ABIRATERONE 154229-19-3 ACLATONIUM NAPADISILATE 55077-30-0 ABITESARTAN 137882-98-5 ACODAZOLE 79152-85-5 ABLUKAST 96566-25-5 ACOLBIFENE 182167-02-8 ABRINEURIN 178535-93-8 ACONIAZIDE 13410-86-1 ABUNIDAZOLE 91017-58-2 ACOTIAMIDE 185106-16-5 ACADESINE 2627-69-2 ACOXATRINE 748-44-7 ACAMPROSATE 77337-76-9 ACREOZAST 123548-56-1 ACAPRAZINE 55485-20-6
    [Show full text]
  • Vr Meds Ex01 3B 0825S Coding Manual Supplement Page 1
    vr_meds_ex01_3b_0825s Coding Manual Supplement MEDNAME OTHER_CODE ATC_CODE SYSTEM THER_GP PHRM_GP CHEM_GP SODIUM FLUORIDE A12CD01 A01AA01 A A01 A01A A01AA SODIUM MONOFLUOROPHOSPHATE A12CD02 A01AA02 A A01 A01A A01AA HYDROGEN PEROXIDE D08AX01 A01AB02 A A01 A01A A01AB HYDROGEN PEROXIDE S02AA06 A01AB02 A A01 A01A A01AB CHLORHEXIDINE B05CA02 A01AB03 A A01 A01A A01AB CHLORHEXIDINE D08AC02 A01AB03 A A01 A01A A01AB CHLORHEXIDINE D09AA12 A01AB03 A A01 A01A A01AB CHLORHEXIDINE R02AA05 A01AB03 A A01 A01A A01AB CHLORHEXIDINE S01AX09 A01AB03 A A01 A01A A01AB CHLORHEXIDINE S02AA09 A01AB03 A A01 A01A A01AB CHLORHEXIDINE S03AA04 A01AB03 A A01 A01A A01AB AMPHOTERICIN B A07AA07 A01AB04 A A01 A01A A01AB AMPHOTERICIN B G01AA03 A01AB04 A A01 A01A A01AB AMPHOTERICIN B J02AA01 A01AB04 A A01 A01A A01AB POLYNOXYLIN D01AE05 A01AB05 A A01 A01A A01AB OXYQUINOLINE D08AH03 A01AB07 A A01 A01A A01AB OXYQUINOLINE G01AC30 A01AB07 A A01 A01A A01AB OXYQUINOLINE R02AA14 A01AB07 A A01 A01A A01AB NEOMYCIN A07AA01 A01AB08 A A01 A01A A01AB NEOMYCIN B05CA09 A01AB08 A A01 A01A A01AB NEOMYCIN D06AX04 A01AB08 A A01 A01A A01AB NEOMYCIN J01GB05 A01AB08 A A01 A01A A01AB NEOMYCIN R02AB01 A01AB08 A A01 A01A A01AB NEOMYCIN S01AA03 A01AB08 A A01 A01A A01AB NEOMYCIN S02AA07 A01AB08 A A01 A01A A01AB NEOMYCIN S03AA01 A01AB08 A A01 A01A A01AB MICONAZOLE A07AC01 A01AB09 A A01 A01A A01AB MICONAZOLE D01AC02 A01AB09 A A01 A01A A01AB MICONAZOLE G01AF04 A01AB09 A A01 A01A A01AB MICONAZOLE J02AB01 A01AB09 A A01 A01A A01AB MICONAZOLE S02AA13 A01AB09 A A01 A01A A01AB NATAMYCIN A07AA03 A01AB10 A A01
    [Show full text]
  • EUROPEAN PHARMACOPOEIA 10.0 Index 1. General Notices
    EUROPEAN PHARMACOPOEIA 10.0 Index 1. General notices......................................................................... 3 2.2.66. Detection and measurement of radioactivity........... 119 2.1. Apparatus ............................................................................. 15 2.2.7. Optical rotation................................................................ 26 2.1.1. Droppers ........................................................................... 15 2.2.8. Viscosity ............................................................................ 27 2.1.2. Comparative table of porosity of sintered-glass filters.. 15 2.2.9. Capillary viscometer method ......................................... 27 2.1.3. Ultraviolet ray lamps for analytical purposes............... 15 2.3. Identification...................................................................... 129 2.1.4. Sieves ................................................................................. 16 2.3.1. Identification reactions of ions and functional 2.1.5. Tubes for comparative tests ............................................ 17 groups ...................................................................................... 129 2.1.6. Gas detector tubes............................................................ 17 2.3.2. Identification of fatty oils by thin-layer 2.2. Physical and physico-chemical methods.......................... 21 chromatography...................................................................... 132 2.2.1. Clarity and degree of opalescence of
    [Show full text]
  • Pharmaceutical Compoundingand Dispensing, Second
    Pharmaceutical Compounding and Dispensing Pharmaceutical Compounding and Dispensing SECOND EDITION John F Marriott BSc, PhD, MRPharmS, FHEA Professor of Clinical Pharmacy Aston University School of Pharmacy, UK Keith A Wilson BSc, PhD, FRPharmS Head of School Aston University School of Pharmacy, UK Christopher A Langley BSc, PhD, MRPharmS, MRSC, FHEA Senior Lecturer in Pharmacy Practice Aston University School of Pharmacy, UK Dawn Belcher BPharm, MRPharmS, FHEA Teaching Fellow, Pharmacy Practice Aston University School of Pharmacy, UK Published by the Pharmaceutical Press 1 Lambeth High Street, London SE1 7JN, UK 1559 St Paul Avenue, Gurnee, IL 60031, USA Ó Pharmaceutical Press 2010 is a trade mark of Pharmaceutical Press Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society of Great Britain First edition published 2006 Second edition published 2010 Typeset by Thomson Digital, Noida, India Printed in Great Britain by TJ International, Padstow, Cornwall ISBN 978 0 85369 912 5 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, without the prior written permission of the copyright holder. The publisher makes no representation, express or implied, with regard to the accuracy of the information contained in this book and cannot accept any legal responsibility or liability for any errors or omissions that may be made. The right of John F Marriott, Keith A Wilson, Christopher A Langley and Dawn Belcher to be identified as the author of this work has been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
    Harmonized Tariff Schedule of the United States (2008) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM GADOCOLETICUM 280776-87-6 ABAFUNGIN 129639-79-8 ACIDUM LIDADRONICUM 63132-38-7 ABAMECTIN 65195-55-3 ACIDUM SALCAPROZICUM 183990-46-7 ABANOQUIL 90402-40-7 ACIDUM SALCLOBUZICUM 387825-03-8 ABAPERIDONUM 183849-43-6 ACIFRAN 72420-38-3 ABARELIX 183552-38-7 ACIPIMOX 51037-30-0 ABATACEPTUM 332348-12-6 ACITAZANOLAST 114607-46-4 ABCIXIMAB 143653-53-6 ACITEMATE 101197-99-3 ABECARNIL 111841-85-1 ACITRETIN 55079-83-9 ABETIMUSUM 167362-48-3 ACIVICIN 42228-92-2 ABIRATERONE 154229-19-3 ACLANTATE 39633-62-0 ABITESARTAN 137882-98-5 ACLARUBICIN 57576-44-0 ABLUKAST 96566-25-5 ACLATONIUM NAPADISILATE 55077-30-0 ABRINEURINUM 178535-93-8 ACODAZOLE 79152-85-5 ABUNIDAZOLE 91017-58-2 ACOLBIFENUM 182167-02-8 ACADESINE 2627-69-2 ACONIAZIDE 13410-86-1 ACAMPROSATE
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2011) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2011) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • Method of Treating a Fabric
    (19) TZZ¥ZZ _T (11) EP 3 088 502 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 02.11.2016 Bulletin 2016/44 C11D 3/386 (2006.01) (21) Application number: 16167242.3 (22) Date of filing: 27.04.2016 (84) Designated Contracting States: (72) Inventors: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB • LANT, Neil Joseph GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO Newcastle upon Tyne, NE12 9TS (GB) PL PT RO RS SE SI SK SM TR • WOOD, Rebecca Louise Designated Extension States: Newcastle upon Tyne, NE12 9TS (GB) BA ME • GUMMEL, Jeremie Robert Marcel Designated Validation States: Newcastle upon Tyne, NE12 9TS (GB) MA MD (74) Representative: Peet, Jillian Wendy (30) Priority: 29.04.2015 EP 15165814 Procter & Gamble Technical Centres Limited 15.10.2015 EP 15190045 Whitley Road Longbenton (71) Applicant: The Procter & Gamble Company Newcastle upon Tyne Cincinnati, OH 45202 (US) NE12 9TS (GB) (54) METHOD OF TREATING A FABRIC (57) Method for treating a hydrophobically-modified textile with an aqueous solution of a nuclease enzyme, preferably a deoxyribonuclease or ribonuclease enzyme, rinsing and drying the textile. Use of the finishing step for improved cleaning with an aqueous solution of a nuclease enzyme, preferably a deoxyribonuclease or ribonuclease enzyme EP 3 088 502 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 088 502 A1 Description FIELD OF INVENTION 5 [0001] This invention relates to methods of treating textile surfaces. BACKGROUND OF THE INVENTION [0002] Fabric whiteness is a constant challenge for laundry detergent manufacturers.
    [Show full text]